SCD1 inhibitor-4

CAS No. 1295541-87-5

SCD1 inhibitor-4( —— )

Catalog No. M23453 CAS No. 1295541-87-5

SCD1 inhibitor-4 is stearoylCoA desaturase-1 (SCD1) inhibitor. SCD1 inhibitor-4 can be used for the research of diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 65 In Stock
2MG 36 In Stock
5MG 55 In Stock
10MG 101 In Stock
25MG 202 In Stock
50MG 319 In Stock
100MG 458 In Stock
200MG 637 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SCD1 inhibitor-4
  • Note
    Research use only, not for human use.
  • Brief Description
    SCD1 inhibitor-4 is stearoylCoA desaturase-1 (SCD1) inhibitor. SCD1 inhibitor-4 can be used for the research of diabetes.
  • Description
    SCD1 inhibitor-4 is stearoylCoA desaturase-1 (SCD1) inhibitor. SCD1 inhibitor-4 can be used for the research of diabetes.
  • In Vitro
    ——
  • In Vivo
    SCD1 inhibitor-4 (1~30 mg/kg) shows a dose-dependent decrease in desaturation index with a 55 % reduction at 1 mg/kg and 85% reduction at the 10 and 30 mg/kg doses.
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    SCD1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1295541-87-5
  • Formula Weight
    363.34
  • Molecular Formula
    C17H16F3N5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 90 mg/mL?(247.70 mM;?Need ultrasonic)
  • SMILES
    O=C(C1=C(C)N(CC2=CC=CC(C(F)(F)F)=C2)C=N1)NC3=NN(C)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Atkinson KA, et al. N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors. Bioorg Med Chem Lett. 2011;21(6):1621-1625.
molnova catalog
related products
  • Lithium citrate trib...

    Lithium Citrate is the active component of Lithium which is a drug used in treatment of psychiatric disease.

  • GSK864

    GSK864 is an IDH1 mutant inhibitor that inhibits IDH1 mutants R132C, R132H, and R132G, and is used in the study of cardiovascular and oncology diseases.

  • AGI-5198

    AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants with IC50 of 0.07 μM/0.16 μM.